This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): FluCide-I, NV-INF-1
Description: NV-INF-1 is an anti-influenza clinical drug candidate designed from nanoviricide technology.
A nanoviricide is designed to specifically seek and attach to a virus particle, engulfing the virus particle in the process, thereby theoretically rendering it incapable of infecting new cells.
Pink Sheet Weekly Trademark Review Nov. 12, 2013
Pink Sheet Weekly Trademark Review July 30, 2013
Additional information available to subscribers only: